Exabis Library
Welcome to the e-CCO Library!
P347: Practical recommendations for the collection of the patient-reported outcomes included in the Health Outcomes Observatory (H2O) core data set for patients with inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P347: Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P347: Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P347: Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P348 Clinical outcomes and response predictors of vedolizumab treatment for anti-TNF-failed patients with IBD in Korea: A prospective multicenter cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P348: 3D reconstructions in complex fistulising perianal Crohn’s disease to aid decision-making
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P348: Correlation between Mayo endoscopic score and validated histological score in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P348: Disease trajectories in ulcerative colitis: Early identification of patients with endoscopic remission at Week 52
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P348: Novel model of care: the effect of a combined inflammatory bowel disease and antenatal clinic
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P348: Perception of cancer risk in inflammatory bowel disease-associated dysplasia and management practice is influenced by colonoscopy experience and workplace affiliation: results of an international clinician survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P348: Persistent hyperCKemia during infliximab therapy in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P348: Top down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P349 Infliximab in inflammatory bowel disease: Is premedication necessary?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P349: Cyclosporine has no clinically meaningful effect on pharmacokinetics (PK) of BMS-986165, an oral selective tyrosine kinase 2 (TYK2) inhibitor, in healthy subjects
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P349: Deep enteroscopy with a through-the-scope ballon catheter system in paediatric patients with IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P349: Faecal Calprotectin in Ulcerative Colitis - Associations with Mucosal Inflammatory Activity and Disease Extent
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P349: Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU).
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P349: The effects of smoking on thiopurine metabolism
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P349: The therapies influencing postoperative surgical recurrence in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM